Skip to main content

Logout

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

Therapeutic Area
Therapeutic Area

At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we plan in generations. We work together globally and with integrity. Our Focus articulates who we are and what we strive for, how we work and what we want to achieve.

Section Overview

Therapeutic Area

Section Overview

Metabolic

Cardiovascular

Respiratory
Products
Products

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products.

See all products

Products

See all products
Resources
Contact
Logout

Boehringer Ingelheim

Feedback

IPF
PPF
SSc-ILD
Mechanism of Action
Prescribing information
Advancing PF Care

FACE IPF

HEAD ON

and modify disease progression by slowing lung function decline

SA-Ofev-Banner

Treatment of patients with PPF and CTD-ILD

07/06/2026 | Author: Boehringer Ingelheim

PC-SA-102964 Respiratory OFEV

Document ID: PC-SA-102964 | Expiry Date: 05/18/2028

Ofev

PPF

Identify Patients With RA-ILD Who Can Benefit From OFEV
How to understand and manage limited cutaneous SSc-ILD
Safety Profile of OFEV
Treatment of patients with PPF and CTD-ILD

Related content

PDF

Safety Profile of OFEV

PC-SA-102973 (June 2028 )

Download Opens in new tab

How to understand and manage limited cutaneous SSc-ILD

PDF

How to understand and manage limited cutaneous SSc-ILD

PC-SA-102972 (June 2028 )

Download Opens in new tab

pc-sa-101935 respiratory - specialty ofev.jpg

PDF

Identify Patients With RA-ILD Who Can Benefit From OFEV

PC-SA-101935 (August 2026 )

Download Opens in new tab

Was this content helpful wrapper

Did you find this content helpful?

Like

Dislike

Like Unlike Wrapper

Like Text Wrapper

Could you share the aspects of the content you were satisfied with? We will continue to create good content with your feedback.

I am generally satisfied with the content

The content was of appropriate length

The format of the content was good

The information shared was relevant and sufficient

Unlike text wrapper

How can we create better content? Share your feedback:

The content was not relevant to the topic

The content was too long

I think important points were skipped

There were repeated topics

Leave this field blank

Home
Respiratory | Therapeutic Area
Ofev
Treatment of patients with PPF and CTD-ILD

Step1

How was your experience in our website?

Help us improve your BI experience by answering just 2 questions

buttons-wrapper

Remind me Later

Step2

Rating wrapper

How was your experience in our website?

How can we improve? step1 wrapper

Your opinion is important for us

I am content with the website experience

Page design needs to improve

Content depth is not satisfactory

There was a technical issue

Loading issues

Other

How can we improve? Step1 wrapper Rating greater than 3

How can we improve? Please tick all the options that apply to you.

Simplify the layout

Improve search

Improve visual design

Clear navigation

Increase content relevance

Contents can be more up to date

Step3

Please indicate your satisfaction title wrapper

Please indicate your satisfaction with the following website:

Very Satisfied
Slightly satisfied
Dissatisfied

Multiple Radios buttons wrapper

Clarity of information

Clarity of information

Very Satisfied

Slightly satisfied

Dissatisfied

Visual presentation

Visual presentation

Very Satisfied

Slightly satisfied

Dissatisfied

Relevancy of content

Suitability of content

Very Satisfied

Slightly satisfied

Dissatisfied

step4

Thank you very much for your valuable feedback.

Your opinions are valuable to us!

Leave this field blank

Sitemap

Therapeutic Area

Resources
- Videos
- Clinical studies

Site Map
Privacy
Terms of use
Contact

BI

.

© 2010-2023 Boehringer Ingelheim International GmbH. All rights reserved. PC-SA-102596